Skip to main content
. 2015 Apr 29;6(19):17379–17390. doi: 10.18632/oncotarget.3954

Table 3. The Cox regression analyses of Disease-free survival (DFS) and TMEM100 expression level as well as clinicopathological parameters.

Univariable analysis Multivariable analysis
Variables HR (95% CI) P HR (95% CI) P
Gender(Male vs. Female) 0.912 (0.387 - 1.981) 0.513
Age(≤60 vs. > 60 ) 0.778 (0.342 – 2.711) 0.611
HBsAg(Negative vs. Positive) 0.882 (0.621 - 2.629) 0.571
Cirrhosis(Presence vs. Absence) 1.758 (1.241 - 7.642) 0.038 1.708 (0.898 – 4.824) 0.061
Child-Pugh Score(Grade A vs. B) 0.821 (0.392 - 2.231) 0.772
AFP level(ng/ml, ≤ 20 vs. > 20) 0.736 (0.229 - 1.791) 0.338
Tumor size(>5 vs. ≤5 cm) 1.847 (0.872 - 2.932) 0.119
Capsular formation(Presence vs. Absence) 0.621 (0.423 – 1.118) 0.082 0.808 (0.232 – 1.635) 0.649
Tumor nodule number(Solitary vs. Multiple) 0.483 (0.288 – 0.896) 0.036 0.421 (0.244 – 0.985) 0.028
Edmondson-Steiner Stage(I-II vs. III-IV) 0.462 (0.311 – 1.276) 0.242
Vein invasion(Presence vs. Absence) 1.586 (1.112 – 2.783) 0.013 1.898(1.087 – 3.824) 0.017
TMEM100 expression(Low vs. High) 2.128 (1.132 – 5.217) 0.009 2.612 (1.227 – 4.561) 0.026